mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.52 |
0.0004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0006 |